Stay updated on Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the site navigation. The site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check17 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now displays a 403 Forbidden error with the site chrome (header/footer) instead of the study details; this indicates an access/permissions issue rather than a new feature or data update.SummaryDifference17%

- Check45 days agoChange DetectedThe page shows a new revision identifier (v3.7.0) replacing the previous v3.6.6, indicating a system/template update rather than substantive changes to the study details.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.6.6 appears in the page footer, replacing the previous Revision: v3.6.5. This signals a minor update to the page metadata without changing any study details or functionality.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now shows Revision: v3.6.5 where Revision: v3.6.4 was previously displayed, indicating a routine site update.SummaryDifference0.1%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.